Construction and Comprehensive Analysis of a CeRNA Network to Reveal Potential Prognostic Biomarkers for Lung Adenocarcinoma

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2021 Jul 24

PMID 34301211

Citations 13

Authors

Lei Gao

Ling Zhang

Affiliations

Soon will be listed here.

Abstract

Background: More and more studies have proven that circular RNAs (circRNAs) play vital roles in cancer development via sponging miRNAs. However, the expression pattern of competing endogenous RNA (ceRNA) in lung adenocarcinoma (LUAD) remains largely unclear. The current study explored functional roles and the regulatory mechanisms of circRNA as ceRNAs in LUAD and their potential impact on LUAD patient prognosis.

Methods: In this study, we systematically screened differential expression circRNAs (DEcircRNAs), miRNAs (DEmiRNAs) and mRNAs (DEGs) associated with LUAD. Then, DEcircRNAs, DEmiRNAs and DEGs were selected to construct a circRNA-miRNA-mRNA prognosis-related regulatory network based on interaction information from the ENCORI database. Subsequently, the gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis were performed on the genes in the network to predict the potential underlying mechanisms and functions of circRNAs in LUAD. In addition, Kaplan-Meier survival analysis was performed to evaluate clinical outcomes of LUAD patients, and drug sensitivity analysis was used to screen potential biomarkers for drug treatment of patients with LUAD.

Results: As a result, 10 circRNAs were aberrantly expressed in LUAD tissues. The ceRNA network was built, which included 3 DEcircRNAs, 6 DEmiRNAs and 157 DEGs. The DEGs in the ceRNA network of hsa_circ_0049271 enriched in biological processes of cell proliferation and the Jak-STAT signaling pathway. We also detected 7 mRNAs in the ceRNA network of hsa_circ_0049271 that were significantly associated with the overall survival of LUAD patients (P < 0.05). Importantly, four genes (PDGFB, CCND2, CTF1, IL7R) identified were strongly associated with STAT3 activation and drugs sensitivity in GDSC.

Conclusions: In summary, a ceRNA network of hsa_circ_0049271 was successfully constructed, which including one circRNA, two miRNAs, and seven mRNAs. Seven mRNAs (PDGFB, TNFRSF19, CCND2, CTF1, IL11RA, IL7R and MAOA) were remarkably associated with the prognosis of LUAD patients. Among seven mRNA species, four genes (PDGFB, CCND2, CTF1, and IL7R) could be considered as drug targets in LUAD. Our research will provide new insights into the prognosis-related ceRNA network in LUAD.

Citing Articles

Prognostic value of CTF1 in glioma and its role in the tumor microenvironment.

He J, Guo J, Sun P Transl Cancer Res. 2025; 13(12):6862-6879.

PMID: 39816535 PMC: 11730202. DOI: 10.21037/tcr-24-1258.

Relationship between CTF1 gene expression and prognosis and tumor immune microenvironment in glioma.

Cai H, Tian S, Liu A, Xie G, Zhang H, Wu X Eur J Med Res. 2025; 30(1):17.

PMID: 39780198 PMC: 11715937. DOI: 10.1186/s40001-024-02192-w.

The bioinformatics analysis and experimental validation of the carcinogenic role of EXO1 in lung adenocarcinoma.

Sun B, Zhang J, Wang N, Zhang Z, Wu Y, Xie M Front Oncol. 2025; 14():1492725.

PMID: 39777332 PMC: 11703735. DOI: 10.3389/fonc.2024.1492725.

Identification of circRNA-miRNA-mRNA networks to explore underlying mechanism in lung cancer.

Wang Y, Fu Y Health Inf Sci Syst. 2024; 13(1):5.

PMID: 39676897 PMC: 11645342. DOI: 10.1007/s13755-024-00318-2.

Exploring the relationship between the interleukin family and lung adenocarcinoma through Mendelian randomization and RNA sequencing analysis.

Zhi F, Liu W, Yang H, Luo H, Feng Y, Lei Y Discov Oncol. 2024; 15(1):436.

PMID: 39264458 PMC: 11393260. DOI: 10.1007/s12672-024-01325-1.

References

Glazar P, Papavasileiou P, Rajewsky N . circBase: a database for circular RNAs. RNA. 2014; 20(11):1666-70. PMC: 4201819. DOI: 10.1261/rna.043687.113. View

Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

Kristensen L, Hansen T, Veno M, Kjems J . Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2017; 37(5):555-565. PMC: 5799710. DOI: 10.1038/onc.2017.361. View

Shang Q, Yang Z, Jia R, Ge S . The novel roles of circRNAs in human cancer. Mol Cancer. 2019; 18(1):6. PMC: 6325800. DOI: 10.1186/s12943-018-0934-6. View

Rybak-Wolf A, Stottmeister C, Glazar P, Jens M, Pino N, Giusti S . Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed. Mol Cell. 2015; 58(5):870-85. DOI: 10.1016/j.molcel.2015.03.027. View

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

Zeng K, He B, Yang B, Xu T, Chen X, Xu M . The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer. 2018; 17(1):160. PMC: 6240936. DOI: 10.1186/s12943-018-0914-x. View

Hirsch F, Scagliotti G, Mulshine J, Kwon R, Curran Jr W, Wu Y . Lung cancer: current therapies and new targeted treatments. Lancet. 2016; 389(10066):299-311. DOI: 10.1016/S0140-6736(16)30958-8. View

Hansen T, Jensen T, Clausen B, Bramsen J, Finsen B, Damgaard C . Natural RNA circles function as efficient microRNA sponges. Nature. 2013; 495(7441):384-8. DOI: 10.1038/nature11993. View

10.

Wang J, Zhao X, Wang Y, Ren F, Sun D, Yan Y . circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis. 2020; 11(1):32. PMC: 6965119. DOI: 10.1038/s41419-020-2230-9. View

11.

Iorio F, Knijnenburg T, Vis D, Bignell G, Menden M, Schubert M . A Landscape of Pharmacogenomic Interactions in Cancer. Cell. 2016; 166(3):740-754. PMC: 4967469. DOI: 10.1016/j.cell.2016.06.017. View

12.

Gao N, Ye B . Circ-SOX4 drives the tumorigenesis and development of lung adenocarcinoma via sponging miR-1270 and modulating PLAGL2 to activate WNT signaling pathway. Cancer Cell Int. 2020; 20:2. PMC: 6942331. DOI: 10.1186/s12935-019-1065-x. View

13.

Ma L, Huang Y, Zhu W, Zhou S, Zhou J, Zeng F . An integrated analysis of miRNA and mRNA expressions in non-small cell lung cancers. PLoS One. 2011; 6(10):e26502. PMC: 3203153. DOI: 10.1371/journal.pone.0026502. View

14.

Zeng K, Chen X, Xu M, Liu X, Hu X, Xu T . CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis. 2018; 9(4):417. PMC: 5856798. DOI: 10.1038/s41419-018-0454-8. View

15.

Wang X, Zhu X, Zhang H, Wei S, Chen Y, Chen Y . Increased circular RNA hsa_circ_0012673 acts as a sponge of miR-22 to promote lung adenocarcinoma proliferation. Biochem Biophys Res Commun. 2018; 496(4):1069-1075. DOI: 10.1016/j.bbrc.2018.01.126. View

16.

Yang X, Tang Z, Zhang P, Zhang L . [Research Advances of JAK/STAT Signaling Pathway in Lung Cancer]. Zhongguo Fei Ai Za Zhi. 2019; 22(1):45-51. PMC: 6348154. DOI: 10.3779/j.issn.1009-3419.2019.01.09. View

17.

Zhao J, Li L, Wang Q, Han H, Zhan Q, Xu M . CircRNA Expression Profile in Early-Stage Lung Adenocarcinoma Patients. Cell Physiol Biochem. 2017; 44(6):2138-2146. DOI: 10.1159/000485953. View

18.

Siegel R, Miller K, Jemal A . Cancer statistics, 2020. CA Cancer J Clin. 2020; 70(1):7-30. DOI: 10.3322/caac.21590. View

19.

Hang D, Zhou J, Qin N, Zhou W, Ma H, Jin G . A novel plasma circular RNA circFARSA is a potential biomarker for non-small cell lung cancer. Cancer Med. 2018; 7(6):2783-2791. PMC: 6010816. DOI: 10.1002/cam4.1514. View

20.

Qi L, Li Y, Qin Y, Shi G, Li T, Wang J . An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy. Br J Cancer. 2016; 115(12):1513-1519. PMC: 5155365. DOI: 10.1038/bjc.2016.370. View